Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Survival of motor neuron 2 (SMN2) pre-mRNA intronic splicing silencer N1 (ISS-N1) is a 15-nucleotide regulatory sequence located in intron 7 of the SMN2 gene [1.1.1]. In patients with spinal muscular atrophy (SMA), the loss of the SMN1 gene makes them dependent on the nearly identical SMN2 gene; however, a single nucleotide difference in SMN2 leads to the frequent skipping of exon 7, resulting in a truncated and unstable SMN protein [1.1.4, 1.2.1]. ISS-N1 acts as a potent inhibitory element that recruits negative splicing factors, such as heterogeneous nuclear ribonucleoproteins (hnRNP A1 and A2), to suppress exon 7 inclusion [1.2.1, 1.2.4]. Therapeutic intervention using antisense oligonucleotides, such as Nusinersen, specifically targets and masks the ISS-N1 sequence [1.2.5]. This masking prevents the binding of repressor proteins, effectively promoting the inclusion of exon 7 during pre-mRNA splicing [1.2.1, 1.2.5]. Consequently, this increases the production of full-length, functional SMN protein, which is essential for the survival and maintenance of motor neurons [1.1.4, 1.4.3].
Antisense oligonucleotide binding to the ISS-N1 site prevents the recruitment of splicing repressor proteins such as hnRNP A1 and A2, thereby promoting the inclusion of exon 7 in the SMN2 transcript and increasing the production of functional SMN protein.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Survival of motor neuron 2 pre-mRNA intronic splicing silencer N1 (ISS-N1).